Cargando…
Can methylene blue dye be used as an alternative to patent blue dye to find the sentinel lymph node in breast cancer surgery?
BACKGROUND: Sentinel lymph node biopsy (SLNB) is standard care to evaluate axillary involvement in early breast cancer. It has fewer complications than complete lymph node dissection; however, using blue dye in SLNB is controversial. We have evaluated the detection rate and local complications assoc...
Autores principales: | Fattahi, Asieh Sadat, Tavassoli, Alireza, Rohbakhshfar, Omid, Sadeghi, Ramin, Abdollahi, Abbas, Forghani, Mohammad Naser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274565/ https://www.ncbi.nlm.nih.gov/pubmed/25538772 |
Ejemplares similares
-
Use of Fluorescence Imaging in Combination with Patent Blue Dye versus Patent Blue Dye Alone in Sentinel Lymph Node Biopsy in Breast Cancer
por: Tong, Meng, et al.
Publicado: (2014) -
Injecting Patent Blue Dye V for sentinel lymph node biopsy without skin staining
por: Johnson, S, et al.
Publicado: (2012) -
Retrospective analysis of sentinel lymph node biopsy using methylene blue dye for early breast cancer
por: Yang, Shan, et al.
Publicado: (2021) -
Sentinel lymph node identification by blue dye in patients with breast carcinoma
por: Bakhtiar, Nighat, et al.
Publicado: (2016) -
Factors that affect the false negative rate of sentinel lymph node mapping with methylene blue dye alone in breast cancer
por: Li, Huang, et al.
Publicado: (2019)